These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


286 related items for PubMed ID: 196820

  • 1. [Therapy of myasthenia gravis].
    Jerusalem F.
    Dtsch Med Wochenschr; 1977 Aug 12; 102(32):1160-3. PubMed ID: 196820
    [No Abstract] [Full Text] [Related]

  • 2. [Therapies of myasthenia gravis (author's transl)].
    de Crousaz G.
    Schweiz Rundsch Med Prax; 1978 Jan 24; 67(4):113-7. PubMed ID: 202937
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of myasthenia gravis].
    Matell G, von Reis G.
    Lakartidningen; 1973 Oct 24; 70(43):3821-5. PubMed ID: 4362569
    [No Abstract] [Full Text] [Related]

  • 4. [Myasthenia gravis. Recent findings and their therapeutic consequences].
    Thümler R, Haferkamp G.
    Dtsch Med Wochenschr; 1979 Oct 05; 104(40):1415-20. PubMed ID: 227650
    [No Abstract] [Full Text] [Related]

  • 5. [Current therapeutic aspects of myasthenia gravis].
    Avilés Mejias S, Ledro Molina D, Garrido Peralta M.
    Rev Clin Esp; 1981 Oct 31; 163(2):139-44. PubMed ID: 6276943
    [No Abstract] [Full Text] [Related]

  • 6. Management of myasthenia gravis.
    Lancet; 1972 Apr 08; 1(7754):780-1. PubMed ID: 4111252
    [No Abstract] [Full Text] [Related]

  • 7. [Immunosuppressive therapy of myasthenia gravis].
    Lechner H, Ott E, Aranibar A.
    Nervenarzt; 1976 Jun 08; 47(6):353-6. PubMed ID: 183158
    [No Abstract] [Full Text] [Related]

  • 8. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J.
    Tidsskr Nor Laegeforen; 1971 Apr 20; 91(11):821-4. PubMed ID: 4326179
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drainage of thoracic duct lymph in twelve patients with myasthenia gravis.
    Bergström K, Franksson C, Matell G, Nilsson BY, Persson A, von Reis G, Stensman R.
    Eur Neurol; 1975 Apr 20; 13(1):19-30. PubMed ID: 165080
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of myasthenia].
    Fève JR.
    Rev Prat; 1988 Oct 06; 38(22):1541-5. PubMed ID: 3206137
    [No Abstract] [Full Text] [Related]

  • 12. Corticotropin therapy in myasthenia gravis: indications and limitations.
    Namba T, Shapiro MS, Brunner NG, Grob D.
    Neurology; 1970 Apr 06; 20(4):385. PubMed ID: 4327339
    [No Abstract] [Full Text] [Related]

  • 13. [Drug therapy in myasthenia gravis].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1971 Apr 10; 91(10):726-8. PubMed ID: 4325239
    [No Abstract] [Full Text] [Related]

  • 14. [Thymectomy in the management of myasthenia].
    Balzereit F, Bay V, Otto H, Rittmeyer P, Sobirey C.
    Z Neurol; 1972 Apr 10; 201(2):136-59. PubMed ID: 4112645
    [No Abstract] [Full Text] [Related]

  • 15. [Immunosuppressive treatment in neurological disorders].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1973 Jun 30; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapeutic considerations in myasthenia gravis].
    Vejvalka J.
    Cesk Neurol Neurochir; 1984 Mar 30; 47(2):78-84. PubMed ID: 6705094
    [No Abstract] [Full Text] [Related]

  • 18. Effects of some immunosuppressive procedures on myasthenia gravis.
    Matell G, Bergström K, Franksson C, Hammarström L, Lefvert AK, Möller E, von Reis G, Smith E.
    Ann N Y Acad Sci; 1976 Mar 30; 274():659-76. PubMed ID: 183592
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Symposium on therapeutic controversies. Myasthenia gravis. Steroids and immunosuppressive drugs.
    Johns TR, Howard FM.
    Trans Am Neurol Assoc; 1978 Mar 30; 103():278-81. PubMed ID: 229611
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.